Epstein-Barr Virus (EBV) Acute Infection Antibodies Profile
Epstein-Barr Virus (EBV) Acute Infection Antibodies Profile
    
Number
216655
CPT
86663; 86664; 86665 (x2)
Synonyms
EBV ; EBV Acute Infection Antibodies
Test Includes
EBV-EA, IgG; EBV-VCA, IgG; EBV-VCA, IgM; Epstein-Barr nuclear antigen antibodies (EBNA); interpretation
Specimen
Serum
Volume
2 mL
Minimum Volume
1 mL
Container
Red-top tube or gel-barrier tube
Storage Instructions
Maintain specimen at room temperature.
Reference Interval
See individual tests.
Use
Differentiation of acute from chronic or reactivated infections with Epstein-Barr virus
Methodology
Multiplex bead flow cytometry
Additional Information
Epstein-Barr virus is a herpes group virus which is ubiquitous. It is the cause of classic infectious mononucleosis, and is causally implicated in the pathogenesis of Burkitt lymphoma, some nasopharyngeal carcinomas, and rare hereditary lymphoproliferative disorders. The serologic response to EB virus includes antibody to early antigen, IgM and IgG antibodies to viral capsid antigen (VCA), and antibodies to nuclear antigen (EBNA).

Although most cases of infectious mononucleosis can be diagnosed on the basis of clinical findings, blood count and morphology, and a positive test for heterophil antibody, as many as 20% may be heterophil-negative, at least at presentation (heterophil may become positive when repeated in a few days). In some of these cases, a test for Epstein-Barr virus antibodies may be useful.

The most controversial use of EBV serology is in chronic fatigue syndrome, a complaint predominantly but not exclusively of young to middle-aged women, characterized by long persistent debilitating fatigue and a panoply of usually mild somatic complaints. The high levels of EBV antibodies in the general population, their long persistence, and the poor correlation of antibody titers with symptoms combine to make EBV serology useless in diagnosing, following, or ruling out chronic fatigue syndrome. See table.

EBV Interpretation


 VCA-IgG VCA-IgM EA-IgG EBV-NA 
Susceptible 
Acute infection ± 
Convalescent phase ± ± 
Chronic or reactivated ± 
Old infection ± 
Antibody present: + 
Antibody absent: - 

Copyright © 2007 by Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved